Item 1A. Risk Factors
Item 1A. Risk Factors
In addition to the other information set forth
below and elsewhere in this Report, you should carefully consider the factors discussed in Part I, Item 1A “Risk Factors”
of the Company’s Annual Report on Form 10-K for the year ended September 30, 2022. Such factors, if they were to occur, could
cause our actual results to differ materially from those expressed in our forward-looking statements in this Report, and materially adversely
affect our financial condition or future results. Although we are not aware of any other factors that we currently anticipate will cause
our forward-looking statements to differ materially from our future actual results, or materially affect the Company’s financial
condition or future results, additional risks and uncertainties not currently known to us or that we currently deem to be immaterial might
materially adversely affect our actual business, financial condition and/or operating results.
We have been the victim of a cyber-related crime and our controls
may not be successful in avoiding further cyber-related crimes in the future.
In January 2023, we were the victim of a business
email compromise fraud which resulted in our incurring a loss of approximately $0.1 million. We are working with law enforcement authorities
and the banks involved in the wire transfer to pursue recovery of the $0.1 million, but at this time we do not know whether we will be
able to recover such funds. Enhancements have been made to our controls relating to electronic payments by or for us that we believe will
reduce our risk of becoming a victim of future frauds related to our payments, including by wire transfers. However, cyber-related criminal
activities continue to evolve and increase in sophistication, frequency and severity. As a result, the control enhancements that have
been made, and any additional enhancements that may be made in the future, to our controls may not be successful in avoiding our becoming
a victim to further cyber-related crimes.
34
NeuroOne Medical Technologies
Corporation
Form 10-Q
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.